Repligen Price to Earning

RGEN
 Stock
  

USD 188.89  0.72  0.38%   

Repligen fundamentals help investors to digest information that contributes to Repligen's financial success or failures. It also enables traders to predict the movement of Repligen Stock. The fundamental analysis module provides a way to measure Repligen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Repligen stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Price to Earnings Ratio is expected to rise to 85.51 this year. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to rise to about 233.3 M this year.

Repligen Price to Earning Analysis

Repligen's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
 2015 2016 2021 2022 (projected)
Enterprise Value883.44 M978.92 M881.02 M950.58 M
Average Equity118.59 M156.97 M141.28 M152.43 M
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
More About Price to Earning | All Equity Analysis

Current Repligen Price to Earning

    
  154.58 X  
Most of Repligen's fundamental indicators, such as Price to Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Repligen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Repligen Price to Earning Historical Pattern

Today, most investors in Repligen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repligen's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to earning growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Repligen price to earning as a starting point in their analysis.
   Repligen Price to Earning   
Share
       Timeline  
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition

Repligen Accumulated Retained Earnings Deficit

Accumulated Retained Earnings Deficit

(58.13 Million)

Repligen Accumulated Retained Earnings Deficit are quite stable at the moment as compared to the past year. The company's current value of Accumulated Retained Earnings Deficit is estimated at (58.13 Million)
Based on the latest financial disclosure, the price to earning indicator of Repligen is roughly 154 times. This is much higher than that of the Life Sciences Tools & Services sector and notably higher than that of the Health Care industry. The price to earning for all United States stocks is notably lower than that of the firm.

Repligen Price to Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Repligen's direct or indirect competition against its Price to Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Repligen could also be used in its relative valuation, which is a method of valuing Repligen by comparing valuation metrics of similar companies.
Repligen is currently under evaluation in price to earning category among related companies.

Repligen Current Valuation Drivers

We derive many important indicators used in calculating different scores of Repligen from analyzing Repligen's financial statements. These drivers represent accounts that assess Repligen's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Repligen's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee59.56 K30.32 K28.14 K54.33 K415.18 K447.96 K
Revenue Per Employee296.71 K354.07 K355.12 K332.05 K2.17 M2.34 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA24.2 M43.92 M56.31 M109.39 M216.23 M233.31 M

Repligen Fundamentals

About Repligen Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Repligen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Repligen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Repligen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Price to Earnings Ratio 79.25  85.51 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA216.2 M233.3 M
Earnings before Tax10.5 M11.4 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Repligen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Center Now

   

Portfolio Center

All portfolio management and optimization tools to improve performance of your portfolios
All  Next Launch Module

Currently Active Assets on Macroaxis

Additionally, take a look at Repligen Piotroski F Score and Repligen Altman Z Score analysis. Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Repligen Stock analysis

When running Repligen price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine Repligen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.